Evidence map›Paper›PMID 27633857›Full record

ArticleScientific reports2016

Regulation of osteoblast development by Bcl-2-associated athanogene-1 (BAG-1).

Joanna Greenhough, Emmanouil S Papadakis, Ramsey I Cutress, Paul A Townsend, Richard O C Oreffo, Rahul S Tare

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Skeletal Response to Soluble Activin Receptor Type IIB in Mouse Models of Osteogenesis Imperfecta.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2018
    Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Joanna GreenhoughCentre for Human Development, Stem Cells and Regeneration, Institute of Developmental Sciences, University of Southampton, Southampton SO16 6YD, United Kingdom.
Emmanouil S PapadakisCancer Research UK Centre Cancer Sciences Unit, Somers Building, University of Southampton, Southampton SO16 6YD, United Kingdom.
Ramsey I CutressCancer Research UK Centre Cancer Sciences Unit, Somers Building, University of Southampton, Southampton SO16 6YD, United Kingdom.
Paul A TownsendInstitute of Cancer Sciences, Manchester Cancer Research Centre, University of Manchester, Manchester M13 9WL, United Kingdom.
Richard O C OreffoCentre for Human Development, Stem Cells and Regeneration, Institute of Developmental Sciences, University of Southampton, Southampton SO16 6YD, United Kingdom.
Rahul S TareCentre for Human Development, Stem Cells and Regeneration, Institute of Developmental Sciences, University of Southampton, Southampton SO16 6YD, United Kingdom.
University of Southampton · GBUniversity of Manchester · GB

Funding

Biotechnology and Biological Sciences Research Council BB/G010579/1Biotechnology and Biological Sciences Research Council BB/L021072/1
6 · The paper itself

Abstract

BCL-2-associated athanogene-1 (BAG-1) is expressed by osteoblast-lineage cells; early embryonic lethality in Bag-1 null mice, however, has limited the investigation of BAG-1 function in osteoblast development. In the present study, bone morphogenetic protein-2/BMP-2-directed osteogenic differentiation of bone marrow stromal cells (BMSCs) of Bag-1(+/-) (heterozygous) female mice was decreased significantly. Genes crucial for osteogenic differentiation, bone matrix formation and mineralisation were expressed at significantly lower levels in cultures of Bag-1(+/-) BMSCs supplemented with BMP-2, while genes with roles in inhibition of BMP-2-directed osteoblastogenesis were significantly upregulated. 17-β-estradiol (E2) enhanced responsiveness of BMSCs of wild-type and Bag-1(+/-) mice to BMP-2, and promoted robust BMP-2-stimulated osteogenic differentiation of BMSCs. BAG-1 can modulate cellular responses to E2 by regulating the establishment of functional estrogen receptors (ERs), crucially, via its interaction with heat shock proteins (HSC70/HSP70). Inhibition of BAG-1 binding to HSC70 by the small-molecule chemical inhibitor, Thioflavin-S, and a short peptide derived from the C-terminal BAG domain, which mediates binding with the ATPase domain of HSC70, resulted in significant downregulation of E2/ER-facilitated BMP-2-directed osteogenic differentiation of BMSCs. These studies demonstrate for the first time the significance of BAG-1-mediated protein-protein interactions, specifically, BAG-1-regulated activation of ER by HSC70, in modulation of E2-facilitated BMP-2-directed osteoblast development.

Indexed as

AnimalsApoptosisBenzothiazolesBone Marrow CellsBone Morphogenetic Protein 2Cell DifferentiationCell ProliferationCells, CulturedCell SurvivalDNADNA-Binding ProteinsEstrogensFemaleGene Expression RegulationHaploinsufficiencyHeterozygoteBCL2-associated athanogene 1 proteinBenzothiazolesBone Morphogenetic Protein 2DNADNA-Binding ProteinsEstrogensHSC70 Heat-Shock ProteinsPeptidesReceptors, EstrogenThiazolesthioflavin TTranscription Factors

Identifiers

PMID27633857
PMCPMC5025845
OpenAlexW2520258138

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.